期刊文献+

血管紧张素转换酶抑制剂治疗心房纤颤的临床研究 被引量:3

下载PDF
导出
摘要 目的探讨血管紧张素转换酶抑制剂(ACEI)盐酸贝那普利对心房纤颤患者的防治作用及对心功能的影响。方法选取2010年4月—2010年10月我科入院或门诊心房纤颤患者60例,随机分为2组,观察两组患者的治疗有效率、窦律转复率、左心功能不全发生率,随访6个月。结果两组患者的治疗有效率、窦律转复率、左心功能不全发生率比较差异显著。结论血管紧张素转换酶抑制剂有望成为控制心房纤颤的一条新途径。
作者 袁晓利
出处 《实用心脑肺血管病杂志》 2011年第4期594-595,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
  • 相关文献

参考文献4

  • 1LarsH Lindholm, Hans Ibsen, Bjrn Dahl, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Inter - vention For Endpoint reduction in hypertension study (LIFE) : a randomised trial against atenolol [ J]. Lancet, 2002, 359 (5): 1004 - 1010.
  • 2Maggioni AP, Latini R, Carson PE, et al. Valsartan reduces the incidence ofartrial fibril - lation in patients with heart failure: results from the Valsartan Heart Failure Trail ( Val - HEFT) [ J]. Am Heart J, 2005, 149 (2): 548-557.
  • 3Wachtell K, Lehto M, Gerdts E, et al. An -giotensin II receptor blockade reduces new- onset artrial fibrillation and subsequent stroke compared to atenolo. The Losartml Inter-vention for End Point Reduction in Hypertension (LIFE) study [J].J Am Coil Cardio, 2005, 45 (4): 712 -719.
  • 4Kalus JS, Coleman CI, White CM. The im - pact of suppressing the renin angiotensin system on atrial fibrillation [ J ]. J Clin Phar - maco, 2006, 46 (3): 21-28.

同被引文献39

  • 1王士雯.开展老年多病因心衰的临床和基础研究[J].中华老年多器官疾病杂志,2006,5(4):244-245. 被引量:33
  • 2Shiroshita - Takeshita A, Brundel BJ, Nattel S. Atrial fibrillation : bas- ic mechanisms, remodeling and triggers [J]. J Interv Card Electrophys- iol, 2005, 13 (3): 181-193.
  • 3Aviles RJ, Martin DO, Apperson - Hansen C, et al. Inflammation as a risk factor for atrial fibrillation [J]. Circulation, 2003, 108 ( 24 ) : 3006 - 3010.
  • 4Crandall MA, Home BD, Day JD, et al. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive creactive protein incre- mentally and independently [ J ]. Pacing Clin Electrophysiol, 2009, 32 (5) :648 -652.
  • 5Yang Y, Li J, Lin X, et al. Novel KCNA5 loss - of - function muta- tions responsible for atrial fibrillation [ J ]. J Hum Genet, 2009, 54 (5) : 277 - 283.
  • 6Abel T, Fehtr J. Role of rosuvastatin in current lipid - lowering therapy [J]. Orv Hetil, 2010, 151 (35) : 1424- 1428.
  • 7Fauehier L, Pierre B, Labriotle A, et al. Antiarrhythmic effect of sta- tin therapy and atrial fihrillation a meta - analysis of randomized con- trolled trials [J]. J Am Coil Cardiol, 2008, 51 (8) : 828 -835.
  • 8朱文锋.中医常见证诊断标准(上)[J].湖南中医药大学学报,2008,28(5):3-8. 被引量:91
  • 9钟书辉,王家昆,张艳.胺碘酮联合缬沙坦治疗阵发性房颤53例疗效观察[J].海南医学院学报,2010,16(4):445-447. 被引量:4
  • 10张茜.老年阵发性心房颤动患者血浆脑钠肽水平的变化及临床意义[J].中国基层医药,2010,17(6):738-739. 被引量:6

引证文献3

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部